Sustainable from Start to Finish

By Dr. Max Rehberger

…(NHS), for example, will only purchase sustainable medical products from 2030 onwards.[4] [1] https://www.bafa.de/DE/Lieferketten/Multilinguales_Angebot/multilinguales_angebot_node.html [2] https://www.uni-wuerzburg.de/aktuelles/einblick/single/news/gruene-endoskopie-am-ukw/ [3] Scope 1: Emissions that arise directly from the company’s activities. Scope 2: Emissions…

…(NHS), for example, will only purchase sustainable medical products from 2030 onwards.[4] [1] https://www.bafa.de/DE/Lieferketten/Multilinguales_Angebot/multilinguales_angebot_node.html [2] https://www.uni-wuerzburg.de/aktuelles/einblick/single/news/gruene-endoskopie-am-ukw/ [3] Scope 1: Emissions that arise directly from the company’s activities. Scope 2: Emissions…

Continue reading

sustainable design

From design to disposal: Reducing the footprint of single-use drug delivery devices

By Alex Fong

…facilitated. As well as patient demand, regulatory and market forces will determine the pace of change towards greener alternatives. References [i] https://www.whitehouse.gov/briefing-room/statements-releases/2022/06/30/fact-sheet-health-sector-leaders-join-biden-administrations-pledge-to-reduce-greenhouse-gas-emissions-50-by-2030/ [ii] https://www.healthpolicypartnership.com/the-nexus-between-climate-change-and-healthcare/ [iii] https://www.whitehouse.gov/briefing-room/statements-releases/2022/06/30/fact-sheet-health-sector-leaders-join-biden-administrations-pledge-to-reduce-greenhouse-gas-emissions-50-by-2030/ [iv] https://www.europeanpharmaceuticalreview.com/news/190992/could-plastic-alternative-support-environmentally-sustainable-drug-delivery/ [v] https://www.sciencedirect.com/science/article/pii/S2542504821000348…

…facilitated. As well as patient demand, regulatory and market forces will determine the pace of change towards greener alternatives. References [i] https://www.whitehouse.gov/briefing-room/statements-releases/2022/06/30/fact-sheet-health-sector-leaders-join-biden-administrations-pledge-to-reduce-greenhouse-gas-emissions-50-by-2030/ [ii] https://www.healthpolicypartnership.com/the-nexus-between-climate-change-and-healthcare/ [iii] https://www.whitehouse.gov/briefing-room/statements-releases/2022/06/30/fact-sheet-health-sector-leaders-join-biden-administrations-pledge-to-reduce-greenhouse-gas-emissions-50-by-2030/ [iv] https://www.europeanpharmaceuticalreview.com/news/190992/could-plastic-alternative-support-environmentally-sustainable-drug-delivery/ [v] https://www.sciencedirect.com/science/article/pii/S2542504821000348…

Continue reading

medical billing

AI and Human Oversight: A New Era in Reducing Medical Billing Errors

By John T. Bright

…Surprise Expenses in Medical Bills, Study Finds.” com, CBS News, Aug. 2024, www.cbsnews.com/news/medical-bills-denied-coverage-health-insurance-commonwealth-fund/. Lindner, Jannik. “Study Reveals Shocking Medical Billing Errors Statistics Impacting Americans.” org, 17 July 2024, gitnux.org/medical-billing-errors-statistics/. EU…

…Surprise Expenses in Medical Bills, Study Finds.” com, CBS News, Aug. 2024, www.cbsnews.com/news/medical-bills-denied-coverage-health-insurance-commonwealth-fund/. Lindner, Jannik. “Study Reveals Shocking Medical Billing Errors Statistics Impacting Americans.” org, 17 July 2024, gitnux.org/medical-billing-errors-statistics/. EU…

Continue reading

Virtual care

AI-Enabled Healthcare: How Quality Engineering Needs to Evolve to Meet New Challenges

By Qualitest

…Quality Engineering enablers Whilst there are specific challenges to Quality Engineering AI, and nuances to be accounted for, it’s not all bad news. Professionals around the world are working hard…

…Quality Engineering enablers Whilst there are specific challenges to Quality Engineering AI, and nuances to be accounted for, it’s not all bad news. Professionals around the world are working hard…

Continue reading

GenAI

Personalized Care with GenAI-powered risk stratification benefits the care delivery model

By Yunguo Yu

…of this industry, there’s zero room for error. But together, we can build a healthier and safer future powered by GenAI-driven risk stratification. https://www.cdc.gov/chronic-disease/data-research/facts-stats/index.html#:~:text=Ninety%20percent%20of%20the%20nation%27s,significant%20health%20and%20economic%20benefits. https://www.thelancet.com/journals/lansea/article/PIIS2772-3682(24)00002-7/fulltext https://www.sciencedirect.com/science/article/pii/S0099176720303767 https://www.techtarget.com/patientengagement/news/366584782/Using-Risk-Stratification-in-Patient-Engagement-Strategies https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2980345/ https://www.commonwealthfund.org/sites/default/files/documents/___media_files_publications_in_the_literature_2016_aug_1896_hibbard_improving_population_hlt_mgmt_hsr_08_23_2016_itl_v2.pdf https://www.sciencedirect.com/science/article/pii/S0099176720303767…

…of this industry, there’s zero room for error. But together, we can build a healthier and safer future powered by GenAI-driven risk stratification. https://www.cdc.gov/chronic-disease/data-research/facts-stats/index.html#:~:text=Ninety%20percent%20of%20the%20nation%27s,significant%20health%20and%20economic%20benefits. https://www.thelancet.com/journals/lansea/article/PIIS2772-3682(24)00002-7/fulltext https://www.sciencedirect.com/science/article/pii/S0099176720303767 https://www.techtarget.com/patientengagement/news/366584782/Using-Risk-Stratification-in-Patient-Engagement-Strategies https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2980345/ https://www.commonwealthfund.org/sites/default/files/documents/___media_files_publications_in_the_literature_2016_aug_1896_hibbard_improving_population_hlt_mgmt_hsr_08_23_2016_itl_v2.pdf https://www.sciencedirect.com/science/article/pii/S0099176720303767…

Continue reading

medical device scrutiny

Soaring Medical Device Scrutiny: How is the Market Adapting?

The global medical devices market is expected to grow from $542.21 billion in 2024 to $886.80 billion by 2032[1]. As devices become more critical to patient outcomes, regulators around the…

The global medical devices market is expected to grow from $542.21 billion in 2024 to $886.80 billion by 2032[1]. As devices become more critical to patient outcomes, regulators around the…

Continue reading

Bipartisan Policy Center logo

REPORT – The Future of Acute Hospital Care at Home: BPC recommends Congress reauthorization of AHCAH

The Bipartisan Policy Center issued a brief on Wednesday recommending Congressional reauthorization of the pandemic-era Acute Hospital Care at Home waiver for five years so more hospitals and patients can…

The Bipartisan Policy Center issued a brief on Wednesday recommending Congressional reauthorization of the pandemic-era Acute Hospital Care at Home waiver for five years so more hospitals and patients can…

Continue reading

discussion paper

Discussion Paper: Health Equity For Medical Devices

The U.S. Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health (CDRH) has developed a discussion paper, Health Equity For Medical Devices, and seeks input from the public…

The U.S. Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health (CDRH) has developed a discussion paper, Health Equity For Medical Devices, and seeks input from the public…

Continue reading

EU Commission

Q2/2024 Life Science Law Update: Key developments for pharma & device companies in EU

The Q2/24 Life Science and Health Care Law Update covers key trends in the EU and Big Five (France, Germany, Italy, Spain, UK) in life sciences regulatory, corporate, compliance, competition,…

The Q2/24 Life Science and Health Care Law Update covers key trends in the EU and Big Five (France, Germany, Italy, Spain, UK) in life sciences regulatory, corporate, compliance, competition,…

Continue reading

Bridging Regulatory & Reimbursement

Everybody is looking for Evidence — Bridging Regulatory & Reimbursement: Strategies for Success

By Christy Sheehy, PhD, Jenny Levinson

…plan ahead for market access. Our industry develops innovative products to improve human health, and reimbursement gives patients access to these life-changing medical technologies.   1 https://medtechintelligence.com/news_article/fda-issues-updated-draft-guidance-on-use-of-real-world-evidence/ 2 https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-aiml-enabled-medical-devices#resources 3…

…plan ahead for market access. Our industry develops innovative products to improve human health, and reimbursement gives patients access to these life-changing medical technologies.   1 https://medtechintelligence.com/news_article/fda-issues-updated-draft-guidance-on-use-of-real-world-evidence/ 2 https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-aiml-enabled-medical-devices#resources 3…

Continue reading